YSDD: a novel mutation in HBV DNA polymerase confers clinical resistance to lamivudine.Published in:Journal of Viral Hepatitis, 2003, v. 10, n. 4, p. 256, doi. 10.1046/j.1365-2893.2003.00435.xBy:Bozday&idot;, A. M.;Uzunalimoğlu, Ö.;Türky&idot;lmaz, A. R.;Aslan, N.;Sezgin, O.;Sahin, T.;Bozday&idot;, G.;Ç&idot;nar, K.;Pai, S. B.;Pai, R.;Bozkaya, H.;Karayalç&idot;n, S.;Yurdayd&idot;n, C.;Schinazi, R. F.Publication type:Article